Compound information
- Natural Products
- ZC893455
- Molecular Formula
- C15H20N2O3S
- Molecular Weight
- 308.1194635 g/mol
- Structure
-
- IUPAC Name
- N-[4-methyl-3-(1-piperidylsulfonyl)phenyl]prop-2-enamide
- InChI
- InChI=1S/C15H20N2O3S/c1-3-15(18)16-13-8-7-12(2)14(11-13)21(19,20)17-9-5-4-6-10-17/h3,7-8,11H,1,4-6,9-10H2,2H3,(H,16,18)
- InChI Key
- FQYVFLYEIZCLKL-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(C)c(S(=O)(=O)N2CCCCC2)c1
- Source
- ZINC000035219965
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 2.963 |
LogS | -4.24 | LogD | 2.774 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.014 | Pgp substrate | 0.945 |
HIA | 0.968 | F20 % | 0.994 |
F30 % | 0.909 | Caco-2 | -4.817 |
MDCK | -4.779 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.26 | PPB | 94.947 |
VD | 0.67 | Fu | 1.088 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.395 | CYP1A2 substrate | 0.631 |
CYP2A6 substrate | 0.635 | CYP2B6 substrate | 0.575 |
CYP2C19 inhibitor | 0.652 | CYP2C19 substrate | 0.868 |
CYP2C8 substrate | 0.738 | CYP2C9 inhibitor | 0.233 |
CYP2C9 substrate | 0.674 | CYP2D6 inhibitor | 0.023 |
CYP2D6 substrate | 0.767 | CYP2E1 substrate | 0.721 |
CYP3A4 inhibitor | 0.035 | CYP3A4 substrate | 0.959 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.26 | CL | 7.612 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.039 | Hepatotoxicity | 0.868 |
Mutagenicity | 0.024 | Rat Oral Acute Toxicity | 0.042 |
FDAMDD | 0.377 | Skin Sensitization | 0.539 |
Carcinogenicity | 0.249 | Eye Corrosion | 0.008 |
Eye Irritation | 0.392 | Respiratory Toxicity | 0.111 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.644 | IGC50 | 3.762 |
LC50FM | 4.547 | LC50DM | 4.869 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.168 | NR-AR-LBD | 0.376 |
NR-AhR | 0.071 | NR-Aromatase | 0.653 |
NR-ER | 0.385 | NR-ER-LBD | 0.427 |
NR-PPAR-gamma | 0.649 | SR-ARE | 0.873 |
SR-ATAD5 | 0.434 | SR-HSE | 0.081 |
SR-MMP | 0.283 | SR-p53 | 0.298 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.